Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call with Webcast and Upcoming Conference ...
SAN DIEGO, April 28, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its first quarter 2016 financial results …